CBD and Protocatechuic Acid Composition for Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inflammation lack effective solutions that combine the anti-inflammatory and antioxidant properties of cannabinoids like CBD with the potent anti-inflammatory effects of protocatechuic acid, potentially leading to suboptimal therapeutic outcomes due to differing bioavailability and administration routes.
Innovation Solution
A composition comprising a therapeutically effective amount of a cannabinoid, such as CBD, combined with protocatechuic acid, administered simultaneously or in close proximity, utilizing various delivery methods including oral, inhalation, and topical routes to maximize bioavailability and synergistic benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If separate treatments with cannabinoids and protocatechuic acid are used, then each compound can be administered independently, but the therapeutic effectiveness is suboptimal due to lacking synergistic benefits
Solution Approach 1:
The patent combines protocatechuic acid and cannabinoid compounds into a single compositional formulation, merging two previously separate treatments into one integrated therapeutic agent that delivers synergistic anti-inflammatory and antioxidant effects
2Reliability
If different administration routes are used for cannabinoids and protocatechuic acid, then each compound can be optimized for its specific properties, but the treatment complexity increases and bioavailability is reduced
Solution Approach 1:
The patent formulates both protocatechuic acid and cannabinoid compounds in a single compositional formulation that can be administered through a unified route (oral, inhalation, or topical), eliminating the need for multiple separate administration procedures while maintaining optimized bioavailability for both compounds
3Reliability
If current anti-inflammatory treatments are used alone, then the treatment protocol is simple, but the therapeutic outcomes are insufficient due to lacking combined anti-inflammatory and antioxidant properties
Solution Approach 1:
The patent creates a composite therapeutic formulation that integrates protocatechuic acid (providing anti-inflammatory properties) with cannabinoid compounds (providing antioxidant properties), resulting in a multi-functional treatment that addresses both inflammatory and oxidative stress pathways simultaneously
Data Source
AI summary
A composition comprising a therapeutically effective amount of a cannabinoid and protocatechuic acid is provided. The disclosure further provides a method of treating inflammation comprising administering a composition comprising a therapeutically effective amount of a cannabinoid and protocatechuic acid to a patient in need thereof. The disclosure further provides a method of treating inflammation including administering a composition including protocatechuic acid and a composition including a cannabinoid to a patient in need thereof. In embodiments, the composition including protocatechuic acid and the composition including a cannabinoid may be administered simultaneously within about 60 minutes of each other. In embodiments, the cannabinoid includes Cannabidiol (CBD).